Back to Search Start Over

Creation of iPSC line NCHi004-A from a patient with down syndrome and congenital heart defects.

Authors :
Alonzo M
Ye S
Beckman B
Texter K
Garg V
Zhao MT
Source :
Stem cell research [Stem Cell Res] 2023 Sep; Vol. 71, pp. 103156. Date of Electronic Publication: 2023 Jun 24.
Publication Year :
2023

Abstract

Down syndrome is a congenital disorder resulting from an extra full or partial chromosome 21, which is characterized by a spectrum of systemic developmental abnormalities, including those affecting the cardiovascular system. Here, we generated an iPSC line from peripheral blood mononuclear cells of a male adolescent with Down syndrome-associated congenital heart defects through Sendai virus-mediated transfection of 4 Yamanaka factors. This line exhibited normal morphology, expressed pluripotency markers, trisomy 21 karyotype, and could be differentiated into three germ layers. This iPSC line can be used for studying cellular and developmental etiologies of congenital heart defects induced by aneuploidy of chromosome 21.<br />Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.<br /> (Copyright © 2023 The Authors. Published by Elsevier B.V. All rights reserved.)

Details

Language :
English
ISSN :
1876-7753
Volume :
71
Database :
MEDLINE
Journal :
Stem cell research
Publication Type :
Academic Journal
Accession number :
37393719
Full Text :
https://doi.org/10.1016/j.scr.2023.103156